Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Intellipharmaceutics International Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Intellipharmaceutics International Inc market cap is $3.33M.
What is the 52-week high for Intellipharmaceutics International Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Intellipharmaceutics International Inc 52 week high is $0.0001 as of October 10, 2025.
What is the 52-week low for Intellipharmaceutics International Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Intellipharmaceutics International Inc 52 week low is $0.00 as of October 10, 2025.
What is the 50-day moving average of Intellipharmaceutics International Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Intellipharmaceutics International Inc 50-day moving average is $0.00.